InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by SCHWARTZ BRIAN, Director. Officer active across 3 companies, notably Cyclacel Pharmaceuticals, Inc.. Aggregated, 7 filings have been recorded. Activity tracked since 15 June 2021. The latest transaction was disclosed on 29 January 2024 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations7 total
12,500 shares0Common StockSEC:0001104659-24-008862:0
21,219 shares0Common StockSEC:0001104659-23-077650:0
30,919 shares@ US$0.679100.0% of flowCommon StockSEC:0001140361-22-023308:0
15,822 shares0Common StockSEC:0001104659-22-071895:0
2,374 shares0Common StockSEC:0001104659-21-082597
2,374 shares0Common StockSEC:0001104659-21-082597:0
2,847 sharesCommon StockSEC:0001019695-16-000057:0
7 of 7 declarations
About SCHWARTZ BRIAN
Brian Schwartz is a Board Member at Cyclacel Pharmaceuticals, Inc. and INFINITY PHARMACEUTICALS, INC. In these roles, he contributes to the governance of the companies and strategic decision-making. His experience in the pharmaceutical sector allows him to bring valuable insights to help guide development and innovation strategies.
